Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of April 24, 2025, Biolase (BIOL) has a market cap of $439,165 Dollars USD. According to our data, Biolase is ranked No.9276 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Dec 17, 2024 | $439,165 Dollars |
-98.81%
|
| Dec 29, 2023 | $41.06 M |
-98.27%
|
| Dec 30, 2022 | $2.38 B |
-93.33%
|
| Dec 31, 2021 | $35.68 B |
-6.41%
|
| Dec 31, 2020 | $38.13 B |
-24.61%
|
| Dec 31, 2019 | $50.57 B |
-44.17%
|
| Dec 31, 2018 | $90.58 B |
-53.56%
|
| Dec 29, 2017 | $195.06 B |
-67.55%
|
| Dec 30, 2016 | $601.19 B |
66.45%
|
| Dec 31, 2015 | $361.19 B |
-68.02%
|
| Dec 31, 2014 | $1.129 T |
-6.60%
|
| Dec 31, 2013 | $1.209 T |
56.06%
|
| Dec 31, 2012 | $774.86 B |
-26.57%
|
| Dec 30, 2011 | $1.055 T |
52.82%
|
| Dec 31, 2010 | $690.46 B |
-8.38%
|
| Dec 31, 2009 | $753.59 B |
28.19%
|
| Dec 31, 2008 | $587.88 B |
-36.86%
|
| Dec 31, 2007 | $931.14 B |
-73.03%
|
| Dec 29, 2006 | $3.452 T |
9.51%
|
| Dec 30, 2005 | $3.152 T |
-26.20%
|
| Dec 31, 2004 | $4.272 T |
-34.28%
|
| Dec 31, 2003 | $6.500 T |
199.64%
|
| Dec 31, 2002 | $2.169 T |
-2.64%
|
| Dec 31, 2001 | $2.228 T |
237.09%
|
| Dec 29, 2000 | $660.94 B |
-37.20%
|
| Dec 31, 1999 | $1.052 T |
26.49%
|
| Dec 31, 1998 | $832.05 B |
-35.86%
|
| Dec 31, 1997 | $1.297 T |
-17.18%
|
| Dec 31, 1996 | $1.566 T |
14.29%
|
| Dec 29, 1995 | $1.370 T |
250.00%
|
| Dec 30, 1994 | $391.55 B |
-68.00%
|
| Dec 31, 1993 | $1.224 T |
-81.62%
|
| Dec 31, 1992 | $6.656 T |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Abbott Laboratories
ABT
|
$224.14 B |
-0.002 M
|
USA
|
 Intuitive Surgical
ISRG
|
$171.52 B |
-0.000 M
|
USA
|
 Boston Scientific
BSX
|
$140.59 B |
-0.004 M
|
USA
|
 Stryker Corporation
SYK
|
$132.87 B |
-0.002 M
|
USA
|
 Medtronic
MDT
|
$106.93 B |
0.001 M
|
Ireland
|
 Becton Dickinson
BDX
|
$58.09 B |
0.001 M
|
USA
|
 Alcon
ALC
|
$46.44 B |
89.671 M
|
Switzerland
|
 Edwards Lifesciences
EW
|
$41.27 B |
-0.002 M
|
USA
|
 Mindray
300760.SZ
|
$35.73 B |
-0.418 B
|
China
|
 ResMed
RMD
|
$31.49 B |
0.001 M
|
USA
|
 Luxshare Precision
002475.SZ
|
$30.60 B |
-0.766 B
|
China
|
 Terumo
4543.T
|
$27.98 B |
-0.468 B
|
Japan
|
 DexCom
DXCM
|
$26.22 B |
-0.001 M
|
USA
|
 Coloplast
COLO-B.CO
|
$24.57 B |
2.019 B
|
Denmark
|
 Zimmer Biomet
ZBH
|
$19.68 B |
-0.001 M
|
USA
|
 Straumann
STMN.SW
|
$19.24 B |
78.787 M
|
Switzerland
|
 Sonova
SOON.SW
|
$17.86 B |
0.496 B
|
Switzerland
|
 Insulet
PODD
|
$17.31 B |
-0.001 M
|
USA
|
 Abiomed
ABMD
|
$17.18 B |
17.181 B
|
USA
|
 Hologic
HOLX
|
$13.13 B |
-0.000 M
|
USA
|
| Market Cap | = | BIOL Stock Price | * | BIOL Shares Outstanding |
| = | $0.01 | * | 36.60 M | |
| = | $439,165 Dollars |